Swiss National Bank’s Audentes Therapeutics, Inc BOLD Stock Holding History

Swiss National Bank’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-73,900	Closed	-$4.42M	–	2503
2019 Q4	$4.42M	Buy	73,900 +3,400	+5%	+$128K	﹤0.01%	1239
2019 Q3	$1.98M	Buy	70,500 +3,000	+4%	+$102K	﹤0.01%	1659
2019 Q2	$2.56M	Buy	67,500 +1,400	+2%	+$53.8K	﹤0.01%	1548
2019 Q1	$2.58M	Buy	66,100 +2,200	+3%	+$63.1K	﹤0.01%	1496
2018 Q4	$1.36M	Buy	63,900 +20,300	+47%	+$524K	﹤0.01%	1809
2018 Q3	$1.73M	Hold	43,600	–	–	﹤0.01%	1816
2018 Q2	$1.67M	Hold	43,600	–	–	﹤0.01%	1822
2018 Q1	$1.31M	Buy	43,600 +10,400	+31%	+$352K	﹤0.01%	1919
2017 Q4	$1.04M	Buy	+33,200	New	+$912K	﹤0.01%	2079

Swiss National Bank's BOLD Position: Q1 2020 in Review

Swiss National Bank sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 73,900 shares — an estimated $4.42M sold.

Swiss National Bank first reported a position in BOLD in Q4 2017 and held it in 9 quarters. The position peaked at $4.42M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Swiss National Bank reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Swiss National Bank sold 73,900 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.42M.
Swiss National Bank first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 9 quarters.
Swiss National Bank's Audentes Therapeutics, Inc position peaked at $4.42M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.